European Commission orders France to lift ban on acne pillBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4932 (Published 05 August 2013) Cite this as: BMJ 2013;347:f4932
View Full Text
- Sophie Arie
France has been forced to allow sales of Bayer’s acne pill Diane-35 despite its concerns over possible fatal side effects, after the European Commission ruled that the drug was safe.
Sales of Diane-35 (known as Dianette in the United Kingdom) were banned in France in May amid concerns that the drug, which contains cyproterone and ethinyestradiol, could cause thrombosis and pulmonary embolism. The drug …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.